mRNA Vaccine Cuts COVID-Related Guillain-Barr é Risk mRNA Vaccine Cuts COVID-Related Guillain-Barr é Risk
COVID-19 increases the risk for Guillain-Barr é syndrome sixfold, while getting the Pfizer mRNA vaccine lowers risk.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 26, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news

Racial, Ethnic Differences in Pain Management for Acute Injuries Racial, Ethnic Differences in Pain Management for Acute Injuries
A large US study shows racial and ethnic disparities in how paramedics record and treat pain from acute traumatic injury during prehospital transport.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 26, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news

FDA Warns of Hidden Ingredients in Arthritis, Pain Products FDA Warns of Hidden Ingredients in Arthritis, Pain Products
Certain products may contain active ingredients found in prescription-only drugs.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 25, 2023 Category: Drugs & Pharmacology Tags: Rheumatology News Alert Source Type: news

GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin GLP-1s Like Semaglutide: Less Thyroid Cancer Than Insulin
Among people with type 2 diabetes who received a GLP-1 receptor agonist, there was less correlation between this treatment and thyroid cancer than among people with type 2 diabetes treated with insulin.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 25, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

CBT App for Type 2 Diabetes Hits US Market CBT App for Type 2 Diabetes Hits US Market
A novel smartphone app, AspyreRx, that delivers cognitive-behavioral therapy to adults with type 2 diabetes became available for prescribing to US patients on October 16.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 24, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Exercise as Good as Viagra for ED: Study Exercise as Good as Viagra for ED: Study
Men with the most severe erectile dysfunction saw the greatest benefit from working out.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 23, 2023 Category: Drugs & Pharmacology Tags: Urology News Source Type: news

Digital Tool Clarifies Menopause Symptoms Digital Tool Clarifies Menopause Symptoms
A website that helps personalize menopause care garnered strong reviews from clinicians in a UK study.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 23, 2023 Category: Drugs & Pharmacology Tags: Family Medicine/Primary Care News Source Type: news

Biologics After Asthma Exacerbation Biologics After Asthma Exacerbation
Although the study was retrospective, it suggests that the threshold for initiating biologics could potentially be lowered for patients with uncontrolled asthma despite adequate use of inhalers.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 19, 2023 Category: Drugs & Pharmacology Tags: Pulmonary Medicine News Source Type: news

Higher Fracture Risk Not Seen With SGLT2 Inhibitors Higher Fracture Risk Not Seen With SGLT2 Inhibitors
Increased fracture risk seen in short-term studies may have been due to hypovolemia or osmotic diuresis, resulting in falls, rather than an effect on bone.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 19, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news

Caution Urged for Obesity Drugs and Birth Control Pills Caution Urged for Obesity Drugs and Birth Control Pills
GLP-1 agonists can interfere with oral contraceptives, making an unintended pregnancy more likely.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 18, 2023 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news

Navigating Key Endpoints in Oncology Clinical Trials Navigating Key Endpoints in Oncology Clinical Trials
Here ' s a guide to understanding endpoints you will likely encounter in cancer clinical trials.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 18, 2023 Category: Drugs & Pharmacology Tags: Hematology-Oncology News Source Type: news

Metabolic Effects of Estetrol for Postmenopausal Women Metabolic Effects of Estetrol for Postmenopausal Women
Participants taking estetrol experienced beneficial changes across a variety of metabolic measures, according to a new study presented at the Menopause Society.MDedge News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 17, 2023 Category: Drugs & Pharmacology Tags: Ob/Gyn & Women ' s Health News Source Type: news

Don ’t Stop OUD Drugs Before Surgery: Study Don ’t Stop OUD Drugs Before Surgery: Study
Medications for opioid use disorder protect against overdoses and postsurgical complications, researchers found.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 16, 2023 Category: Drugs & Pharmacology Tags: Anesthesiology News Source Type: news

Docs Weigh In on Insurance Coverage for Obesity Medications Docs Weigh In on Insurance Coverage for Obesity Medications
Supply and demand issues and rising costs drove some insurers to cut coverage.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 13, 2023 Category: Drugs & Pharmacology Tags: Internal Medicine News Source Type: news

FDA Approves New Drug for Ulcerative Colitis FDA Approves New Drug for Ulcerative Colitis
Etrasimod is the second oral sphingosine-1-phosphate (S1P) receptor approved in the US for treating moderate to severe active ulcerative colitis in adults.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - October 13, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Alert Source Type: news